A new computer-aided diagnostic tool for non-invasive characterisation of malignant ovarian masses: results of a multicentre validation study
- 191 Downloads
To prospectively assess an innovative computer-aided diagnostic technology that quantifies characteristic features of backscattered ultrasound and theoretically allows transvaginal sonography (TVS) to discriminate benign from malignant adnexal masses.
Women (n = 264) scheduled for surgical removal of at least one ovary in five centres were included. Preoperative three-dimensional (3D)-TVS was performed and the voxel data were analysed by the new technology. The findings at 3D-TVS, serum CA125 levels and the TVS-based diagnosis were compared with histology. Cancer was deemed present when invasive or borderline cancerous processes were observed histologically.
Among 375 removed ovaries, 141 cancers (83 adenocarcinomas, 24 borderline, 16 cases of carcinomatosis, nine of metastases and nine others) and 234 non-cancerous ovaries (107 normal, 127 benign tumours) were histologically diagnosed. The new computer-aided technology correctly identified 138/141 malignant lesions and 206/234 non-malignant tissues (98% sensitivity, 88% specificity). There were no false-negative results among the 47 FIGO stage I/II ovarian lesions. Standard TVS and CA125 had sensitivities/specificities of 94%/66% and 89%/75%, respectively. Combining standard TVS and the new technology in parallel significantly improved TVS specificity from 66% to 92% (p < 0.0001).
Computer-aided quantification of backscattered ultrasound is a highly sensitive for the diagnosis of malignant ovarian masses.
KeywordsOvarian cancer diagnosis Ultrasound Ovarian HistoScanning Tissue characterisation
The following investigators are members of the Ovarian HistoScanning Clinical Study Group:
B Lauratet B, JP Lefranc, PA Grenier: La Pitié—Salpêtrière Hospital, AP—HP, UPMC, Paris, France
K Schedvins K: Karolinska Hospital, Stockholm, Sweden
R di Pace R, D Franchi, M Bellomi, A Maggioni: European Institute of Oncology, Milan, Italy
R Mashiach, I Meizner: Rabin Medical Centre, Petah Tikva, Israel
A Schneider, J Lange: Hospital La Charité, Berlin, Germany
AS Absil, M Solnick, P Hennebert, AR Grivegnée: Jules Bordet Institute, Brussels, Belgium
R Nir, C Soviany: Advanced Medical Diagnostics, SA/NV, Drève Richelle, 161, 1410 Waterloo, Belgium
- 1.Ferlay J, Bray F, Pisani P, Parkin D (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Press, LyonGoogle Scholar
- 4.Myers ER, Bastian LA, Havrilesky LJ et al (2006) Management of adnexal mass. Evid Rep Technol Assess (Full Rep) 130:1–145Google Scholar